Skip to content

Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain

Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain in Patients Undergoing Uniport Thoracoscopic Pulmonary Resection

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05202249
Enrollment
60
Registered
2022-01-21
Start date
2021-11-15
Completion date
2022-05-15
Last updated
2022-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Lung Neoplasms, Postoperative Pain, Pulmonary Neoplasm, Thoracoscopic Surgery

Keywords

chest tube drainage, thoracic drainage, thoracoscopic surgery, Postoperative Pain

Brief summary

Lung cancer is the leading cause of cancer-related death worldwide. Thoracoscopic pulmonary resection is a prevalent management for early stage of lung cancer. Placement of chest tube is the standard procedure after surgery, which causes pain that cannot be ignored. The investigators aimed to determine whether a muscle layer fixation of thoracic drainage tube could release postoperative pain in patients with uniport thoracoscopic pulmonary resection compared with conventional skin fixation.

Interventions

PROCEDUREmuscle layer fixation of thoracic drainage tube

The thoracic drainage tube is fixed on the muscle layer of the uniport

Sponsors

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18\<age\<80; * ASA≤III * Patients with no clinically significant cardiac history, such as ischaemic heart disease, valvular heart disease, rhythm disturbances such as frequent atrial fibrillation or premature ventricular contractions (PVCs). Patients with significant cardiac history should be optimized according the relevant guidelines before surgery is considered. * Normal cardiopulmonary function \[predicted forced expiratory volume in the first second(FEV1%) \>50% and ejection fraction (EF) \>50%of predicted value\]. Resting blood gas analysis showing arterial partial pressure of oxygen (PaO2)≥75 mmHg and arterial partial pressure of carbon dioxide (PaCO2) \<45 mmHg;

Exclusion criteria

* History of ipsilateral surgery and other conditions which can result in extensive pleural adhesion; * Coagulopathy, hypoxemia (PaO2 \<60 mmHg), hypercapnia \[arterial carbon dioxide tension(PaCO2) \>50 mmHg\]; * Significant cardiac history.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative PainFrom date of operation until the date of chest tube removal, assessed up to 7 daysThe postoperative pain is assessed using a Visual Analog Scale (VAS)
Pain-associated inflammatory factorthe first day after surgerythe level of pain-associated inflammatory factor in blood, including CRP, PCT, IL6 and TNFa
Dosage of analgesicsFrom date of operation until the date of chest tube removal, assessed up to 7 daysDosage of analgesics

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026